New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. ÌýYou can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
WELCOME BACK
Our team works together to deliver exceptional endometrial cancer care tailored to your needs. At the Stanford Women’s Cancer Center, we harness the combined experience of our nationally recognized experts. A group of specialists—including pathologists, geneticists, and radiation oncologists—examines each case to recommend the best treatment path.
- Precise diagnosis options that combine advanced biopsy and imaging technologies with the expertise of pathologists and radiologists trained in evaluating uterine cancer.
- Team-based treatment planning, including weekly meetings that bring together specialists from diverse disciplines to tailor care to your needs.
- Minimally invasive treatments that offer faster recovery and shorter hospital stays.
- Tumor genomic profiling services to target the genetic fingerprint of hard-to-treat uterine cancers with novel therapies only available through clinical trials.
- Genetic counseling services to assess your hereditary risk for uterine cancer and develop a care plan for you and your family.
- Comprehensive support services, including nutrition services, massage therapy, and counseling support for sexual side effects and changes in body image.
Connect to Care
Let us help find personalized care options forÌýyou and your family.
Interested in an Online Second Opinion?
The Stanford Medicine Online Second Opinion program offers you easy access to our world-class doctors. It’s all done remotely, and you don’t have to visit our hospital or one of our clinics for this service. You don’t even need to leave home!
Visit our online second opinion page to learn more.
Types of Treatment for Endometrial Cancer
Goals of endometrial cancer treatment
Treatment for endometrial cancer can cure or control the disease. It can also improve your quality of life by relieving symptoms. Treatment options vary greatly depending on:
- Stage (or extent) of the cancer
- Type of cancer and whether it’s slow-growing or fast-growing
- Your age, health history, preferences, and goals
Your care team may recommend surgery to diagnose, stage, or treat cancer:
- Diagnosis: A pathologist who specializes in gynecologic cancers analyzes tissue taken during biopsy or surgery to diagnose endometrial cancer.
- Staging: Surgery can help determine the stage of endometrial cancer by showing the size of the tumor and other details.
- Treatment: Surgery to remove the uterus is an important part of your treatment.
- Hysterectomy: During this procedure, a surgeon removes the uterus. They may also remove the cervix, fallopian tubes, and ovaries.
- Surgery that preserves the ovaries: In some cases, doctors can preserve the function of the ovaries so women can collect their eggs for future use. By collecting their eggs, they may be able to have children through a surrogate in the future. Ovarian preservation is usually appropriate for younger women with early endometrial cancer.
- Laparoscopic surgery: The surgeon uses a small incision and performs the operation by inserting a tiny camera and small surgical tools. Sometimes, surgeons use robotic equipment to guide the tools. These minimally invasive surgeries involve less recovery time and a lower risk of complications than traditional (open) surgery.
- Neoadjuvant therapy: This treatment takes place first to make surgery easier and more effective. Undergoing chemotherapy before surgery, for example, may shrink a tumor and make removal more successful.
- Adjuvant therapy: This treatment occurs after surgery to reduce the risk of the cancer coming back. Chemotherapy or radiation therapy after surgery can destroy remaining cancer cells.
Drug therapy, also called systemic or medical therapy, is treatment that works throughout the body to fight endometrial cancer. These drugs slow the growth of cancer cells or destroy them. At ÌÇÐÄ´«Ã½, our gynecologic oncologists use several types of drug therapy, including:
- Chemotherapy: This group of medications stops the growth of rapidly dividing cells in the body, both cancerous and noncancerous. Although it is powerful, chemotherapy can cause more side effects than other medication types because it cannot distinguish between cancerous and healthy cells. Chemotherapy is a treatment option for many cancers.
- Hormone (endocrine) therapy: Some cancers grow in response to hormones such as estrogen. Hormone therapy lowers the amount of these hormones or blocks their effect, slowing or even stopping the cancer’s growth.
- Immunotherapy: These medications help your body’s own immune system target and destroy cancer cells.
- By mouth (orally) as a pill
- Through the blood vessels (intravenously, or IV) as an injection or infusion
Radiation therapy is painless treatment that uses high-energy X-rays or other types of radiation to destroy cancer cells. Our radiation oncologists have years of experience safely and effectively treating endometrial cancer with radiation. Using the latest technology, we can precisely target tumors and minimize damage to nearby healthy tissue.
Radiation therapy may provide effective treatment for the type of endometrial cancer you have. If so, your doctor will speak with you about the best options. The types of radiation therapy we use for endometrial cancer treatment at ÌÇÐÄ´«Ã½ include:
External radiation
External radiation uses a machine called a linear accelerator (LINAC) to deliver radiation to the area where the cancer cells are located. We’re skilled at using several types of external radiation, including:
- 3D conformal radiation therapy (3D-CRT): With this method, 3D images help the doctor better target the tumor. The images are created using a special machine—a computed tomography (CT) or magnetic resonance imaging (MRI) machine. Your doctor can aim the radiation beams from many different angles to match the exact shape of the cancer.
- Intensity-modulated radiation therapy (IMRT): IMRT is similar to 3D-CRT, but the doctor can adjust how much radiation you get from each beam. In certain situations, this adjustment enables the doctor to avoid nearby healthy cells to reduce the risk of side effects.
- Stereotactic body radiation therapy (SBRT) or stereotactic ablative radiation therapy (SABR): This method works like the first two methods, and the total amount of radiation you get is similar. With SBRT, you receive fewer radiation doses, but each dose is stronger. ÌÇÐÄ´«Ã½ often use SBRT to treat cervical cancers or other cancers.
- Low-dose rate (LDR): The radioactive material stays in place from 1 to 7 days. You may stay in the hospital during that time, and you are radioactive until the doctor removes the radioactive material. At ÌÇÐÄ´«Ã½, we do not perform this type of brachytherapy.
- High-dose rate (HDR): The radioactive material is implanted for only 10 to 20 minutes at a time, then removed. You are not radioactive at any time other than the few minutes of treatment, meaning you can safely be around others when you return home. Most people receive three to six treatments total: once a day, twice a week. Most of the time, you can have treatments as an outpatient (no hospital stay needed) and return home the same day. At ÌÇÐÄ´«Ã½, we exclusively use HDR-brachytherapy.
If you have a strong family history of uterine cancer, you may benefit from our comprehensive genetic risk assessment. With 5% to 10% of uterine cancers tied to hereditary causes, we can help you understand and manage your risk and decide on further intervention. Learn more about our Cancer Genetics Program.
Risk Assessment
Assessing your risk involves looking at your personal medical history and family histories from both sides. We may also suggest genetic testing, using the latest techniques to analyze dozens of genes at once. If you have uterine cancer, the particular pathology also guides testing recommendations.
Throughout the process, our genetic counselors discuss the implications for your health, life, and family. We can help you share results with relatives. Learn more about cancer risk assessment with genetic testing and counseling.
Risk Management
Uterine cancer is typically diagnosed in treatable stages. Still, you may want to consider uterus removal if you have a high-risk, inherited mutation and related cancers in your family. Even if no mutation is found, some women with a strong family history of uterine cancer choose prophylactic surgery.
Depending on your circumstances, you may have the option of minimally invasive, laparoscopic surgery.
Genetic Mutations and Uterine Cancer
Your genes contain needed, inherited information, but some may be missing, duplicated, or miscoded. Several of these changes increase uterine cancer risk. Known mutations tied to uterine cancer include:
- Genes related to Lynch syndrome: Mutations in the MLH1, MSH2, MSH6, PMS2, and EPCAM genes cause most inherited uterine cancers. These mutations also have ties to skin, brain, and colorectal and other gastrointestinal cancers. Together, such familial cancers are called Lynch syndrome, or hereditary nonpolyposis colorectal cancer (HNPCC).
- PTEN: This is one of the main genes tied to Cowden syndrome (a disorder that causes benign growths) and PTEN hamartoma tumor syndrome (PHTS). PTEN mutations can also increase risk for melanoma and breast, thyroid, colorectal, and kidney cancers. Our team has extensive experience treating people with rare conditions, including mutations in PTEN.
- Other genes, including FH, BRCA1, TP53, CHEK2, and POLD1: Mutations in these genes can increase the risk of tumor growth and cancer.
After completing endometrial cancer treatment, your care team works with you to develop an ongoing care plan. Regular follow-up care, also known as surveillance, is important to:
- Check for possible signs of the cancer coming back (recurring)
- Manage any side effects
- Monitor your overall health
Clinical Trials
Clinical trials are ÌÇÐÄ´«Ã½ studies that evaluate a new medical approach, device, drug, or other treatment. As a ÌÇÐÄ´«Ã½ patient, you may have access to the latest, advanced clinical trials through the Stanford Cancer Institute.
Open trials refer to studies that are currently recruiting participants or that may recruit participants soon. Closed trials are not currently enrolling additional patients.
To request an appointment, call 650-498-6000.